医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Sorafenib as third- or fourth-line treatment of advanced gastrointestinal stromal tumour and pretreatment including both imatinib and sunitinib, and nilotinib: A retrospective analysis

广告
第一作者: Montemurro,M.
作者: Montemurro,M. [1] ; Gelderblom,H. [2] ; Bitz,U. [3] ; Schütte,J. [4] ; Blay,J.Y. [5] ; Joensuu,H. [6] ; Trent,J. [7] ; Bauer,S. [8] ; Rutkowski,P. [9] ; Duffaud,F. [10] ; Pink,D.
作者单位: Marien Hospital, Düsseldorf, Germany [1] Department of Hematology, Oncology and Palliative Medicine, HELIOS Klinikum Bad Saarow, Sarcoma [2] Helsinki University Hospital, Helsinki, Finland [3] Department of Soft Tissue / Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer [4] Department of Medical Oncology, University Hospital la Timone, Marseille, France [5] Centre Pluridisciplinaire d' Oncologie, University Hospital Lausanne, Lausanne, Switzerland [6] Department of Clinical Oncology, Leiden University, Medical Center, Leiden, Netherlands [7] Sarcoma Center, University of Essen, Medical School, Essen, Germany [8] Department of Medicine, Centre Léon Bérard, Lyon, France [9] Sarcoma Medical Oncology and the Adult Sarcoma Research Center, University of Texas M.D. Anderson [10]
发布时间 2013-11-20
提交
  • 浏览1
European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷